14 research outputs found

    Metamodel-assisted design optimization of piezoelectric flex transducer for maximal bio-kinetic energy conversion

    Get PDF
    Energy Harvesting Devices (EHD) have been widely used to generate electrical power from the bio-kinetic energy of human body movement. A novel Piezoelectric Flex Transducer (PFT) based on the Cymbal device has been proposed by Daniels et al. (2013) for the purpose of energy harvesting. To further improve the efficiency of the device, optimal design of the PFT for maximum output power subject to stress and displacement constraints is carried out in this paper. Sequential Quadratic Programming (SQP) on metamodels generated with Genetic Programming from a 140-point optimal Latin hypercube design of experiments is used in the optimization. Finally, the optimal design is validated by finite element simulations. The simulations show that the magnitude of the electrical power generated from this optimal PFT harvesting device can be up to 6.5 mw when a safety design factor of 2.0 is applied

    Boron-Based Inhibitors of the NLRP3 Inflammasome.

    Get PDF
    NLRP3 is a receptor important for host responses to infection, yet is also known to contribute to devastating diseases such as Alzheimer's disease, diabetes, atherosclerosis, and others, making inhibitors for NLRP3 sought after. One of the inhibitors currently in use is 2-aminoethoxy diphenylborinate (2APB). Unfortunately, in addition to inhibiting NLRP3, 2APB also displays non-selective effects on cellular Ca2+ homeostasis. Here, we use 2APB as a chemical scaffold to build a series of inhibitors, the NBC series, which inhibit the NLRP3 inflammasome in vitro and in vivo without affecting Ca2+ homeostasis. The core chemical insight of this work is that the oxazaborine ring is a critical feature of the NBC series, and the main biological insight the use of NBC inhibitors led to was that NLRP3 inflammasome activation was independent of Ca2+. The NBC compounds represent useful tools to dissect NLRP3 function, and may lead to oxazaborine ring-containing therapeutics
    corecore